跳至主要内容
临床试验/NCT02294539
NCT02294539已完成4 期

Comparison of Effects Between Calcium Channel Blocker and Diuretics in Combination With Angiotensin II Receptor Blocker on 24-hr Central Blood Pressure and Vascular Hemodynamic Parameters in Hypertensive Patients Multicenter, Double-blind, Active-controlled, Phase 4 Randomized Trial

Chong-Jin Kim1 个研究点 分布在 1 个国家目标入组 231 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
231
试验地点
1
主要终点
change from baseline in msSBP

研究概览

简要总结

The purpose of this study is to investigate which combination therapy is more effective for improving the blood pressure (BP) and AM central SBP in hypertensive patients:Angiotensin II receptor blocker (ARB) plus calcium channel blocker (CCB) or ARB plus diuretics

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hypertension patients not included exclusion criteria
  • Mean seated SBP ≥140mmHg in patients with newly Diagnosed

排除标准

  • msDBP≥110mmHg or ms SBP ≥ 180mmHg at the screening and randomization visit

研究组 & 干预措施

Losartan 50mg/amlodipine 5mg

Experimental

Once daily, 1T, PO medication

干预措施: Losartan 50mg/Hydrochlorothiazide 12.5mg (Drug)

Losartan 100mg/amlodipine 5mg

Experimental

Once daily, 1T, PO medication

干预措施: Losartan 100mg/Hydrochlorothiazide 25mg (Drug)

Losartan50 mg/Hydrochlorothiazide12.5 mg

Active Comparator

Once daily, 1T, PO medication

干预措施: Losartan 50mg/amlodipine 5mg (Drug)

Losartan100 mg/Hydrochlorothiazide25 mg

Active Comparator

Once daily, 1T, PO medication

干预措施: Losartan 100mg/amlodipine 5mg (Drug)

结局指标

主要结局

change from baseline in msSBP

时间窗: 4 weeks

次要结局

  • change from baseline in AMcSBP(20 weeks)

研究者

发起方
Chong-Jin Kim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chong-Jin Kim

Chairman of Cardiovascular Center

Kyung Hee University Hospital at Gangdong

研究点 (1)

Loading locations...

相似试验